The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

The Rock-Star Investors Next Door
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

 David Rose     Graphic_subscribe   

    Start Tracking David Rose  -  Add to Friends  -  Send Message   
    Community Rank: Analyst (128 pts)  |  Member since 06/05/2008
Picks Performance:
Outperforms
21%
of community

All-time Return
-14.23%
(in over 3 years)
Risk (SD)
Moderate
0.00%
Sharpe Ratio
-28.58
Followers
0
Winning Picks
3 of 10
Total Views
6355


 Last Activity: Added C to bullish list on 06/13/08 

Current Stock List:
Symbol SP Sentiment Rating Return Since
C Positive +33.43% 06/13/08
STP Positive -95.15% 06/09/08
EMKR Positive -50.31% 06/09/08
GS Positive -42.91% 06/07/08
FLEX Positive -41.46% 06/05/08
MYL Positive +59.80% 06/05/08
AMD Positive -20.63% 06/05/08
AKNS Positive n/a 06/05/08
CHD Positive -6.56% 06/05/08
SPWRA Positive n/a 06/05/08




Opinion & Analysis
Graphic_rating_buy Bullish on EMKR ...   about EMKR   06/09/08
http://seekingalpha.com/article/79261-shining-light-on-emcore...  



Discussions

David Rose hasn't participated in any discussions yet.



People Following David Rose ...

Nobody is following David Rose.





 
Similarity to Me   ?

Compare Your Portfolio With David Rose:
Enter stocks you like & track your portfolio:

Symbols, separated by space (e.g. AAPL GOOG MSFT)



More about David Rose

Investment Style:
Moderate  [?]

Avg exp holding time:
1329.50 days

Age:
30's

Location:
Oregon



Similar Portfolios
Foto
Marian Filo (supratrade) 62% 100%
Art (unicomtrade.com) N/A 63%
Statistician (optimist) N/A 63%
450vampyr_avatar-med
supratrader (supratrader) N/A 54%
Yorgos Voyiatzis (taxidiotis) 67% 45%



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch